Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.5620.4132.4710.29-

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 9.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29
Mar2020-

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29
0
Mar2020 0 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹742.9 Cr -3.1% -4.9% 6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,478.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,845.0 Cr -7.1% -11.5% 32.7% Stock Analytics
CIPLA ₹120,121.0 Cr -4.3% -0.1% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,327.0 Cr -5.8% 6.1% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,907.8 Cr -5.8% -6.8% -11% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-3.1%

-4.9%

6.6%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses